Board Meeting on Nov 16, 2015
Mangalam Drugs & Organics Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 16, 2015, inter alia to consider and approve the allotment of 12,00,000 Equity Shares on conversion of 12,00,000 Share Warrants which were allotted on preferential basis to Shri J B Pharma LLP, ("Promoter" or "Proposed Allottee") on September 28, 2015 and the issue of which was approved by the shareholders at 42nd Annual... Outcome of Board Meeting
Mangalam Drugs & Organics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 21, 2015, inter alia, has transacted the following business:- The Board of Directors have designated Mr. Brijmohan M Dhoot an existing Executive Director of the Company as the Non-Executive Director of the Company with immediate effect. Financial Results & Limited Review Report for Sept 30, 2015 (Standalone)
Mangalam Drugs & Organics Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015. Revised Shareholding Pattern For September 30, 2015
With reference to earlier announcement dated October 18, 2015 regarding Shareholding Pattern for September 30, 2015, Mangalam Drugs & Organics Ltd has now submitted to BSE the Revised Shareholding Pattern for September 30, 2015. Revised Trading Window Closure dates
Mangalam Drugs & Organics Ltd has informed BSE regarding Revised Trading Window Closure dates. Shareholding Pattern for September 30, 2015
Mangalam Drugs & Organics Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015. Board Intimation for Results & Closure of Trading Window
Mangalam Drugs & Organics Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on October 21, 2015, inter alia, to consider and take on record Unaudited Financial Results for the quarter ended September 30, 2015.Further, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations,... Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Shri JB Pharma LLP has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Updates on Outcome of AGM
Mangalam Drugs & Organics Ltd has submitted to BSE a copy of the minutes of the 42nd Annual General Meeting (AGM) of the Company held on September 03, 2015. Appointment of Company Secretary & Compliance Officer
Mangalam Drugs & Organics Ltd has informed BSE that Ms. Nikita Bavishi has been appointed as the Company Secretary of the Company who will also act as the Compliance Officer of the Company.